Gender specificity of angiogenesis in patients with non-muscle invasive bladder cancer complicated by type 2 diabetes mellitus
- 19 March 2025
- journal article
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 28 (3)
Abstract
Cancers and diabetes mellitus are among the most common human pathologies, with an increase in morbidity every year. To this date, a relationship of type 2 diabetes mellitus (DM2) with increased risk of development and progression of cancer of many localizations has been established, nevertheless the data on the impact of DM2 on the course of bladder cancer are contradictory. Objective. To study the features of expression of angiogenic proteins — vascular endothelial growth factor (VEGF) and platelet endothelial cell adhesion molecule (CD31), to evaluate their gender specificity in non-muscle-invasive bladder cancer, developing in addition to type 2 diabetes mellitus 2, compared with these indicators in bladder cancer emerging without comorbid pathology. Materials and methods. The study was conducted on material of 40 patients of both sexes with a verified urothelial non-muscle-invasive bladder cancer who were treated at «NMRC for Oncology» (Rostov-on-Don) from 2017 to 2022. Monoclonal mouse antibodies to VEGF and CD31 were used for immunohistochemical analysis. Percentage of tumor cells expressing VEGF and number of vessels stained with CD31 marker were determined. Results. A statistically significant exceedance of VEGF expression level by 2.8 times has been noted in patients of the group with DM2 compared to women in the same group (p=0.002) and men without comorbid pathology (p=0.001). The number of CD31-stained vessels was 1.3 times (p=0.042) higher in women of the same group than in men, and 3 times (p=0.009) higher in women without comorbid pathology. Conclusion. The revealed gender specificity of expression of angiogenesis markers in non-muscle-invasive bladder cancer, developing in addition to type 2 diabetes mellitus, can be considered for the prediction of risk of development and progression of this pathology.Keywords
This publication has 18 references indexed in Scilit:
- An Overview of Angiogenesis in Bladder CancerCurrent Oncology Reports, 2023
- Effect of diabetes mellitus and glycemic control on the prognosis of non-muscle invasive bladder cancer: a retrospective studyBMC Urology, 2020
- Diabetes, Glycated Hemoglobin, and Risk of Cancer in the UK Biobank StudyCancer Epidemiology, Biomarkers & Prevention, 2020
- No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progressionPLOS ONE, 2020
- The association between type 2 diabetes mellitus and bladder cancer risk among postmenopausal womenCancer Causes & Control, 2020
- European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 UpdateEuropean Urology, 2019
- Predictive biomarkers for drug response in bladder cancerInternational Journal of Urology, 2019
- The impact of cancer on diabetes outcomesBMC Endocrine Disorders, 2019
- Diabetes mellitus and the risk of bladder cancerMedicine, 2017
- Diabetes and risk of cancer incidence: results from a population-based cohort study in northern ItalyBMC Cancer, 2017